Lextro is a leading Immune modulation & Cytotoxicity focused company developing first-in-class & best-in-class therapeutics for the treatment of Autoimmune, Cancer, Metabolic and Infectious diseases. Our proprietary product pipeline showcases our dedication to revolutionizing healthcare through innovation. Each of our therapies is designed to be multi-specific, addressing specific disease pathways and restoring homeostasis mechanisms to achieve rejuvenation in health.